Dogwood Therapeutics (DWTX) Earnings Analysis

Dogwood Therapeutics (DWTX) next reports earnings on 2026-08-12, consensus EPS -0.13 USD. Last quarter (2026-05-14) it beat with EPS -0.15 USD vs -0.22 USD est (+31.8%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E -0.14.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does DWTX next report earnings?

Next earnings date2026-08-12
Consensus EPS estimate-0.13 USD
Revenue estimaten/a

DWTX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-14-0.15 USD-0.22 USD+31.8%Beat
2026-03-18-0.26 USD-0.86 USD+69.8%Beat
2025-11-06-8.2 USD-1.23 USD-566.7%Miss
2025-08-13-1.99 USD-1.26 USD-57.9%Miss
2025-02-26-5.89701 USD-1.36 USD-333.6%Miss

Beat rate: 2/5 (40%) over reported quarters with consensus data.

DWTX valuation and analyst view

Trailing P/E-0.14
Trailing EPS-0.84422 USD
Price / book0.61
Dividend yield0.00%
Market cap0.00B
Analyst consensusBuy (1 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Dogwood Therapeutics (DWTX)'s next earnings date?

Dogwood Therapeutics is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.13 USD.

Did DWTX beat earnings last quarter?

In its 2026-05-14 report, DWTX posted EPS of -0.15 USD versus a -0.22 USD estimate — a beat of 31.8%.

What is DWTX's earnings track record?

Over the last 5 reported quarters with consensus data, DWTX beat estimates 2 times (40%).

What is DWTX's current P/E ratio and EPS?

DWTX trades at a trailing P/E of -0.14 on trailing EPS of -0.8442165670763125 USD.

What do analysts rate DWTX?

Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell).